[ad_1] Mateon Therapeutics (OTC: MATN) ANALYSIS OF FOCUS PERFORMANCE: PROFITABILITY REPORT: Monitoring of profitability control, company profit margin recorded at 0.00% and operating margin at 0.00%. The institutional ownership of the company is equal to 0.15%, while the ownership of Insiders is equal to 2.91%. The Company has been able …
Read More »MATN) – Bitcoin & Stock Exchange Journal
